Sunday, September 30, 2018

Ajanta Pharma gets USFDA approval for Ranitidine HCL

The market for Ranitidine HCL, in both the strengths, is likely to be less than $100mn and we expect this to be a small drug for Ajanta Pharma.

from India Infoline News Service https://ift.tt/2P1NHSf
Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)